Skip to content
Homepage
Author:
Hopstem Biotechnology Inc.
Posted Date:
June 3, 2026
Hopstem hNPC01 Cell Injection Earns FDA RMAT Designation for Chronic Stroke Therapy
Hopstem Biotechnology Inc.
June 3, 2026
